Skip to main navigation
NextCure, Inc.
  • Home
  • About Us
    • Background
    • Founder
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • FIND-IO™ Technology
  • Pipeline
  • Product Development
  • Partnering
  • Investors
    • Overview
    • News
    • Publications
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
  • Contact

Events and Presentations

Events and Presentations

Past Events
The JMP Securities Life Sciences Conference
May 16, 2023 at 11:30 AM EDT
Listen to webcast
JMP Securities Life Sciences Presentation 5.1 MB
22nd Annual Needham Virtual Healthcare Conference
Apr 19, 2023 at 10:15 AM EDT
Listen to webcast
View Presentation 5.1 MB
Presentations
JMP Securities Life Sciences Presentation
May 2023 Corporate Presentation
NextCure Trial in Progress Poster for NC525 at the 2022 ASH Annual Meeting
SITC 2022 Poster - A phase 1b/2, open-label, safety, tolerability and efficacy study of NC410 plus pembrolizumab for participants with immune checkpoint inhibitor (ICI) refractory or MSS/MSI-low ICI naïve advanced or metastatic solid tumors
SITC 2022 Poster- A phase 1/2, open-label, dose-escalation, safety, and tolerability study of NC762 in subjects with advanced or metastatic solid tumors

Tools

9000 Virginia Manor Road | Suite 200 | Beltsville, MD 20705 | USA | (240) 399-4900